Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection

Korean Journal of Hematology

Volumn 46, Issue 2, 2011, Pages 123-127

  Alavi, Samin ^a   Sharifi, Zohreh ^b   Valeshabad, Ali Kord ^c   Nourbakhsh, Kazem ^a   Shamsian, Bibi Shahin ^a   Arzanian, Mohammad Taghi ^a   Safarisharari, Alieh ^a   Navidinia, Masoumeh ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Blood and Transfusion Organization   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C virus (HCV); Thalassemia; Torque teno virus (TTV)

Indexed keywords

EID: 84859813005     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2011.46.2.123     Document Type: Article

References (29)

1. Okamoto H, Mayumi M. TT virus: virological and genomic characteristics and disease associations. J Gastroenterol 2001;36:519-29.
2. Chen BP, Rumi MG, Colombo M, et al. TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates. Blood 1999;94:4333-6.
3. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
4. Hino S. TTV, a new human virus with single stranded circular DNA genome. Rev Med Virol 2002;12:151-8.
5. Poovorawan Y, Tangkijvanich P, Theamboonlers A, Hirsch P. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease. Hepatogastroenterology 2001;48:256-60.
6. Cossart Y. TTV - a virus searching for a disease. J Clin Virol 2000;17:1-3.
7. Simmonds P. Transfusion virology: progress and challenges. Blood Rev 1998;12:171-7.
8. Blejer JL, Salamone HJ. Is TT virus (TTV) a true hepatitis virus cause? Medicina (B Aires) 2000;60:631-8.
9. Okamoto H, Takahashi M, Nishizawa T, et al. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 1999;259:428-36.
10. Kondili LA, Pisani G, Beneduce F, et al. Prevalence of TT virus in healthy children and thalassemic pediatric and young adult patients. J Pediatr Gastroenterol Nutr 2001;33:629-32.
11. Liweń I, Januszkiewicz-Lewandowska D, Nowak J. TT virus-characteristics, occurrence and routes of transmission. Przegl Epidemiol 2002;56:91-9.
12. Hsu HY, Ni YH, Chen HL, Kao JH, Chang MH. TT virus infection in healthy children, children after blood transfusion, and children with non-A to E hepatitis or other liver diseases in Taiwan. J Med Virol 2003;69:66-71.
13. Davidson F, MacDonald D, Mokili JL, Prescott LE, Graham S, Simmonds P. Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 1999;179:1070-6.
14. Yzèbe D, Xueref S, Baratin D, Boulétreau A, Fabry J, Vanhems P. TT virus. A review of the literature. Panminerva Med 2002;44: 167-77.
15. Tokita H, Murai S, Kamitsukasa H, et al. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Virol 2002;67:501-9.
16. Meng XW, Komatsu M, Goto T, et al. Clinical significance of TT virus in chronic hepatitis C. J Gastroenterol Hepatol 2001;16: 202-8.
17. Cleavinger PJ, Persing DH, Li H, et al. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol 2000;95:772-6.
18. Yuki N, Kato M, Masuzawa M, et al. Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysis. J Med Virol 1999;59:431-6.
19. Charlton M, Adjei P, Poterucha J, et al. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998;28:839-42.
20. Zein NN, Arslan M, Li H, et al. Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol 1999;94:3020-7.
21. Ni YH, Chang MH, Lue HC, et al. Posttransfusion hepatitis C virus infection in children. J Pediatr 1994;124:709-13.
22. Lai MW, Chang MH, Hsu HY. Non-A, non-B, non-C hepatitis: its significance in pediatric patients and the role of GB virus-C. J Pediatr 1997;131:536-40.
23. Chen HL, Chang MH, Ni YH, Hsu HY, Kao JH, Chen PJ. Hepatitis G virus infection in normal and prospectively followed posttransfusion children. Pediatr Res 1997;42:784-7.
24. Hu YW, Al-Moslih MI, Al Ali MT, et al. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. J Med Virol 2008;80:365-71.
25. Sampietro M, Tavazzi D, Martinez di Montemuros F, et al. TT virus infection in adult beta-thalassemia major patients. Haematologica 2001;86:39-43.
26. Ozyürek E, Ergünay K, Kuskonmaz B, et al. Transfusion-transmitted virus prevalence in Turkish patients with thalassemia. Pediatr Hematol Oncol 2006;23:347-53.
27. Erensoy S, Sayiner AA, Türkoǧlu S, et al. TT virus infection and genotype distribution in blood donors and a group of patients from Turkey. Infection 2002;30:299-302.
28. Chan PK, Chik KW, Li CK, et al. Prevalence and genotype distribution of TT virus in various specimen types from thalassaemic patients. J Viral Hepat 2001;8:304-9.
29. Dhenain M, Boulétreau A, Bourguignon F, et al. The TT virus: review of the literature. Clin Invest Med 2000;23:355-65.